By binding to its receptor, insulin activates signaling whose defect plays a role in brain dysfunction, leading to neurodegenerative diseases, especially Alzheimer’s disease (AD) [4]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.